Raffin Thomas A. 4
4 · Akoya Biosciences, Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Raffin Thomas A.
Director
Transactions
- Purchase
Common Stock
2023-06-12$5.00/sh+20,000$100,000→ 234,592 total(indirect: By Trust) - Purchase
Common Stock
2023-06-12$5.00/sh+1,803,373$9,016,865→ 15,937,535 total(indirect: See Footnote) - Purchase
Common Stock
2023-06-12$5.00/sh+196,627$983,135→ 1,737,712 total(indirect: See Footnote)
Footnotes (2)
- [F1]Shares held directly by THP III Affiliates Fund, LLC ("THP III AFF"). Telegraph Hill Partners III Investment Management, LLC ("THP IM") is the manager of THP III AFF. Telegraph Hill Partners Management Company, LLC ("THPMC") is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III AFF. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- [F2]Shares held directly by Telegraph Hill Partners III, L.P. ("THP III"). THP IM is the general partner of THP III. THPMC is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.